Volume 74, December 2014, Pages 265–269
Short communication
Inhibition of monoamine oxidase (MAO) by α-ethylphenethylamine and N,α-diethylphenethylamine, two compounds related to dietary supplements
Highlights
- •
- AEPEA was a stronger MAO A inhibitor (Ki = 14.0 µM) vs. N,α-DEPEA (Ki = 251 µM).
- •
- AEPEA and N,α-DEPEA were weak MAO B inhibitors (Ki > 159 µM).
- •
- Ki for MAO A: amphetamine < AEPEA ≈ methamphetamine < phentermine < N,α-DEPEA.
Abstract
Phenethylamines
can interact with the metabolic enzyme monoamine oxidase (MAO), which
can cause neurochemical dysfunction or changes in drug potency. A
methamphetamine analog, N,α-diethylphenethylamine (N,α-DEPEA),
was recently discovered in athletic performance-enhancing supplements,
along with discovery of its metabolite, α-ethylphenethylamine (AEPEA).
In vitro inhibition of human recombinant MAO by AEPEA and N,α-DEPEA
was evaluated by measuring the fluorescence of 4-hydroxyquinoline
produced from MAO substrate, kynuramine. AEPEA competitively inhibited
human recombinant MAO A (Ki = 14.0 µM), which was 17-fold stronger compared to MAO B (Ki = 234 µM). Furthermore, N,α-DEPEA was a weak inhibitor of both MAO A (Ki = 251 µM) and MAO B (Ki
= 159 µM). Trends regarding MAO A inhibition were explored among
structural analogs, yielding the following ranking: amphetamine (Ki = 5.3 µM), AEPEA (Ki = 14.0 µM), methamphetamine (Ki = 17.2 µM), phentermine (Ki = 196 µM), and N,α-DEPEA (Ki
= 251 µM). This study provides important data relating chemical
structures and biochemical effects for two emerging compounds associated
with dietary supplements.
Abbreviations
- AEPEA, α-ethylphenethylamine;
- N,α-DEPEA, N,α-diethylphenethylamine;
- MAO, monoamine oxidase;
- SEM, standard error of the mean
Keywords
- Monoamine oxidase (MAO);
- N-ethyl-1-phenyl-2-butanamine;
- 1-phenyl-2-butanamine;
- Enzyme inhibition;
- Amphetamines;
- Diethylphenethylamines
Published by Elsevier Ltd.